Fang Q, You C, Xiao X, Liu Y, et al. Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting. Protein Pept Lett 2025 Sep 3. doi: 10.2174/0109298665403178250806111943.
PMID: 40916434